CompletedPhase 2

Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.

Egypt46 participantsStarted 2021-01-17

Plain-language summary

Thyroidectomy is considered a common operation with moderate to severe postoperative pain in some patients. Patients are divided into two groups. Bupivacaine group received bilateral superficial cervical plexus block (BSCPB) with 10 ml of bupivacaine (0.25%) and 1 ml of normal saline on each side and the Bupivacaine Ketorolac group received (BSCPB) with 10 ml of bupivacaine (0.25%) and 1 ml of ketorolac (15 mg) on each side.

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 20-50 years * ASA I-II patients * Patients going to do thyroid surgeries under general anesthesia Exclusion Criteria: * Patient refusal * Known history of sensitivity to the drug used in the study * Drug abuse * Infection at the site of the block * Presence of coagulopathy

What they're measuring

1st analgesic requirement

Timeframe: 24 hours

Trial details

NCT IDNCT05180214

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08-19

View on ClinicalTrials.gov More Thyroid Goiter trials